MARKET

COCP

COCP

Cocrystal Pharma Inc
NASDAQ
1.100
-0.020
-1.79%
After Hours: 1.100 0 0.00% 16:10 08/13 EDT
OPEN
1.110
PREV CLOSE
1.120
HIGH
1.150
LOW
1.100
VOLUME
35.95K
TURNOVER
--
52 WEEK HIGH
2.670
52 WEEK LOW
0.7600
MARKET CAP
15.17M
P/E (TTM)
-1.5052
1D
5D
1M
3M
1Y
5Y
1D
Cocrystal Pharma Q2 EPS $(0.23) Misses $(0.17) Estimate, Sales $105.000K
Benzinga · 9h ago
Weekly Report: what happened at COCP last week (0803-0807)?
Weekly Report · 3d ago
Top Insider Makes Bold New Move on Cocrystal Pharma Stock
TipRanks · 08/06 02:07
OPKO Health Boosts Stake in Cocrystal Pharma Financing
TipRanks · 08/03 11:48
Cocrystal Pharma announces $5M investment from Opko Health
TipRanks · 08/03 11:25
Cocrystal Pharma Secures $5M Investment From OPKO Health To Advance Norovirus Program Toward Phase 1b Data
Benzinga · 08/03 11:01
Weekly Report: what happened at COCP last week (0727-0731)?
Weekly Report · 08/03 09:25
Weekly Report: what happened at COCP last week (0720-0724)?
Weekly Report · 07/27 09:27
More
About COCP
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company. The Company is engaged in discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), noroviruses and hepatitis C viruses (HCV). It is developing small molecule antiviral therapeutics that inhibit the essential viral replication function of RNA viruses, causing acute and chronic viral diseases. It has several candidates under development for the treatment of influenza infection. CC-42344 is a novel PB2 inhibitor, which is a preclinical lead for the treatment of pandemic and seasonal influenza A. It also develops broad-spectrum influenza antivirals targeting replication enzymes of influenza A and B strains. Its broad-spectrum antiviral drug candidate, CDI-988, is an oral treatment for SARS-CoV-2, the virus that causes COVID-19. Its CC-31244, an HCV NNI, is a pan-genotypic inhibitor of NS5B polymerase for the treatment of HCV.

Webull offers Cocrystal Pharma Inc stock information, including NASDAQ: COCP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, COCP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading COCP stock methods without spending real money on the virtual paper trading platform.